• Burcon published its MD&A for the year ended March 31, 2026, citing material uncertainty over going concern.
• Accumulated deficit reached CAD 164.5 million; working capital swung to negative CAD 10.6 million.
• Net loss widened to CAD 14.3 million; operating cash outflow increased to CAD 9.2 million.
• Commercial production and sales started at the Protein Production Facility for Peazazz pea, PurateinC canola, FavaPro fava proteins.
• Manufacturing Agreement with ProMan treated as a lease; lease liability was CAD 15.62 million; fixed fee totals USD 19.8 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burcon NutraScience Corporation published the original content used to generate this news brief on June 26, 2026, and is solely responsible for the information contained therein.